MARKET

ASND

ASND

Ascendis Pharma
NASDAQ
115.94
-2.90
-2.44%
Closed 13:00 11/25 EST
OPEN
118.86
PREV CLOSE
118.84
HIGH
120.37
LOW
115.30
VOLUME
193.30K
TURNOVER
0
52 WEEK HIGH
147.97
52 WEEK LOW
61.58
MARKET CAP
6.61B
P/E (TTM)
-13.8157
1D
5D
1M
3M
1Y
5Y
Ascendis Pharma to Participate in the 5th Annual Evercore ISI HealthCONx Conference
COPENHAGEN, Denmark, Nov. 22, 2022 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) announced today that the company is scheduled to participate in the 5th Annual Evercore ISI HealthCONx Conference. Company executives will participate in a virtual fi...
GlobeNewswire · 6d ago
Ascendis, Visen' once-weekly growth hormone drug beats daily hGH in Chinese patients in trial
Seekingalpha · 11/17 10:01
Morgan Stanley Maintains Overweight on Ascendis Pharma, Raises Price Target to $148
Benzinga · 11/15 13:13
Why Infinity Pharmaceuticals Shares Tumbled Around 38%; Here Are 79 Biggest Movers From Yesterday
Benzinga · 11/15 10:19
--Morgan Stanley Adjusts Price Target on Ascendis Pharma to $148 From $146, Maintains Overweight Rating
--Morgan Stanley Adjusts Price Target on Ascendis Pharma to $148 From $146, Maintains Overweight Rating
MT Newswires · 11/15 08:49
Why Opiant Pharmaceuticals Shares Are Trading Higher By 115%? Here Are 53 Stocks Moving In Monday's Mid-Day Session
Benzinga · 11/14 18:05
SVB Leerink Maintains Outperform on Ascendis Pharma, Lowers Price Target to $148
Benzinga · 11/14 17:11
Hasbro, Ascendis Pharma, Coinbase Global And Some Other Big Stocks Moving Lower On Monday
Benzinga · 11/14 15:57
More
About ASND
Ascendis Pharma A/S is a Denmark-based company that manufactures pharmaceutical products. The Company produces products for the treatments of growth hormone deficiency, endocrinology, central nervous system disorders, infectious diseases, and diabetes. The Company operates globally though its subsidiaries: Ascendis Pharma GmbH (Germany), Ascendis Pharma, Inc. (Delaware, United States), Ascendis Pharma Endocrinology, Inc. (Delaware, United States), Ascendis Pharma, Ophthalmology Division A/S (Denmark), Ascendis Pharma, Endocrinology Division A/S (Denmark), Ascendis Pharma Bone Diseases A/S (Denmark), Ascendis Pharma Growth Disorders A/S (Denmark) and Ascendis Pharma Oncology Division A/S (Denmark).

Webull offers kinds of Ascendis Pharma A/S stock information, including NASDAQ:ASND real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ASND stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ASND stock methods without spending real money on the virtual paper trading platform.